Activation of plasminogen activator inhibitor implicates protease InhA in the acute-phase response to Bacillus anthracis infection

Journal of Medical Microbiology

Volumn 58, Issue 6, 2009, Pages 737-744

  Chung, Myung Chul ^a   Jorgensen, Shelley C ^a,b   Popova, Taissia G ^a   Tonry, Jessica H ^a   Bailey, Charles L ^a   Popov, Serguei G ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; D DIMER; HAPTOGLOBIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE INHA; PROTEINASE; SERUM AMYLOID A; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; INFLAMMATION; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOSIS;

ACUTE-PHASE PROTEINS; ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; FEMALE; HAPTOGLOBINS; HUMANS; INFLAMMATION; LIVER; METALLOPROTEASES; MICE; MICE, INBRED DBA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SPORES, BACTERIAL; THROMBOSIS; UP-REGULATION;

EID: 66449098781     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.007427-0     Document Type: Article

References (39)

1. Ascenzi, P. & Fasano, M. (2007). Heme-hemopexin: a 'chronosteric' heme-protein. IUBMB Life 59, 700-708.
2. Baumann, H. & Gauldie, J. (1994). The acute phase response. Immunol Today 15, 74-80. (Pubitemid 24049800)
3. Beaufort, N., Wojciechowski, P., Sommerhoff, C. P., Szmyd, G., Dubin, G., Eick, S., Kellermann, J., Schmitt, M., Potempa, J. & Magdolen, V. (2008). The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem J 410, 157-165.
4. Biemond, B. J., Levi, M., Ten Cate, H., van der Poll, T., Büller, H. R., Hack, C. E. & Ten Cate, J. W. (1995). Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci (Lond) 88, 587-594.
5. Birgel, M., Gottschling-Zeller, H., Röhrig, K. & Hauner, H. (2000). Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes. Arterioscler Thromb Vasc Biol 20, 1682-1687.
6. Chitlaru, T., Gat, O., Grosfeld, H., Inbar, I., Gozlan, Y. & Shafferman, A. (2007). Identification of in vivo-expressed immunogenic proteins by serological proteome analysis of the Bacillus anthracis secretome. Infect Immun 75, 2841-2852. (Pubitemid 46870165)
7. Chung, M. C., Popova, T. G., Millis, B. A., Mukherjee, D. V., Zhou, W., Liotta, L. A., Petricoin, E. F., Chandhoke, V., Bailey, C. & Popov, S. G. (2006). Secreted neutral metalloproteases of Bacillus anthracis as candidate pathogenic factors. J Biol Chem 281, 31408-31418. (Pubitemid 46041405)
8. Chung, M. C., Jorgensen, S. C., Popova, T. G., Bailey, C. L. & Popov, S. G. (2008a). Neutrophil elastase and syndecan shedding contribute to antithrombin depletion in murine anthrax. FEMS Immunol Med Microbiol 54, 309-318.
9. Chung, M. C., Popova, T. G., Jorgensen, S. C., Dong, L., Chandhoke, V., Bailey, C. L. & Popov, S. G. (2008b). Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy. J Biol Chem 283, 9531-9542.
10. Dong, J., Fujii, S., Goto, D., Furumoto, T., Kaneko, T., Zaman, T. A., Nakai, Y., Mishima, T., Imagawa, S. & Kitabatake, A. (2003). Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives. Hypertens Res 26, 723-729. (Pubitemid 37258660)
11. Duan, X. (2005). Immunodepletion of albumin for two-dimensional gel detection of new mouse acute-phase protein and other plasma proteins. Proteomics 5, 3991-4000. (Pubitemid 41502494)
12. Gruys, E., Van Ederen, A. M., Alsemgeest, S. P. M., Kalsbeek, H. C. & Wensing, T. (1993). Acute-phase protein values in blood of cattle as indicator of animals with pathological processes. Arch Lebensmittelhyg 44, 107-111. (Pubitemid 23802527)
13. Gruys, E., Obwolo, M. J. & Toussaint, M. J. M. (1994). Diagnostic significance of the major acute phase proteins in veterinary clinical chemistry: a review. Vet Bull 64, 1009-1018.
14. Gutierrez, F. R., Lalu, M. M., Mariano, F. S., Milanezi, C. M., Cena, J., Gerlach, R. F., Santos, J. E., Torres-Dueñas, D., Cunha, F. Q. & other authors (2008). Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis 197, 1468-1476.
15. Heffernan, B. J., Thomason, B., Herring-Palmer, A. & Hanna, P. (2007). Bacillus anthracis anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax. FEMS Microbiol Lett 271, 98-105. (Pubitemid 46701071)
16. Hoffman, J. S. & Benditt, E. P. (1982). Changes in high density lipoprotein content following endotoxin administration in the mouse: formation of serum amyloid protein-rich subfractions. J Biol Chem 257, 10510-10517. (Pubitemid 13252252)
17. Kastrup, C. J., Boedicker, J. Q., Pomerantsev, A. P., Moayeri, M., Bian, Y., Pompano, R. R., Kline, T. R., Sylvestre, P., Shen, F. & other authors (2008). Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'. Nat Chem Biol 4, 742-750.
18. Komori, Y., Nonogaki, T. & Nikai, T. (2001). Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 39, 1327-1332. (Pubitemid 32510962)
19. Kruithof, E. K. (1988). Plasminogen activator inhibitors: a review. Enzyme 40, 113-121. (Pubitemid 18185455)
20. Kruithof, E. K., Gudinchet, A. & Bachmann, F. (1988). Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost 59, 7-12. (Pubitemid 18053642)
21. Kushner, I. & Mackiewicz, A. (1987). Acute phase proteins as disease markers. Dis Markers 5, 1-11. (Pubitemid 17063156)
22. Lee, C.-C. & Huang, T.-S. (2005). Plasminogen activator inhibitor-1: the expression, biological functions, and effects on tumorigenesis and tumor cell adhesion and migration. J Cancer Mol 1, 25-36.
23. Lin, W.-W. & Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117, 1175-1183. (Pubitemid 46718402)
24. Liu, R. M. (2008). Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal 10, 303-319.
25. Moayeri, M., Haines, D., Young, H. A. & Leppla, S. H. (2003). Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest 112, 670-682. (Pubitemid 38057708)
26. Narasaki, R., Kuribayashi, H., Shimizu, K., Imamura, D., Sato, T. & Hasumi, K. (2005). Bacillolysin MA, a novel bacterial metalloproteinase that produces angiostatin-like fragments from plasminogen and activates protease zymogens in the coagulation and fibrinolysis systems. J Biol Chem 280, 14278-14287. (Pubitemid 40517330)
27. Park, J. M., Ng, V. H., Maeda, S., Rest, R. F. & Karin, M. (2004). Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. J Exp Med 200, 1647-1655. (Pubitemid 40094188)
28. Popov, S. G., Popova, T. G., Grene, E., Klotz, F., Cardwell, J., Bradburne, C., Jama, Y., Maland, M., Wells, J. & other authors (2004). Systemic cytokine response in murine anthrax. Cell Microbiol 6, 225-233. (Pubitemid 38248006)
29. Rocha, E., Páramo, J. A., Montes, R. & Panizo, C. (1998). Acute generalized, widespread bleeding. Diagnosis and management. Haematologica 83, 1024-1037.
30. Sherer, K., Li, Y., Cui, X. & Eichacker, P. Q. (2007). Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy. Am J Respir Crit Care Med 175, 211-221. (Pubitemid 46203123)
31. Stearns-Kurosawa, D. J., Lupu, F., Taylor, F. B., Kinasewitz, G. & Kurosawa, S. (2006). Sepsis and pathophysiology of anthrax in a nonhuman primate model. Am J Pathol 169, 433-444. (Pubitemid 44156306)
32. Steel, D. M. & Whitehead, A. S. (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15, 81-88. (Pubitemid 24049801)
33. Sutterwala, F. S., Ogura, Y. & Flavell, R. A. (2007). The inflammasome in pathogen recognition and inflammation. J Leukoc Biol 82, 259-264. (Pubitemid 47230635)
34. Theilgaard-Mö nch, K., Jacobsen, L. C., Nielsen, M. J., Rasmussen, T., Udby, L., Gharib, M., Arkwright, P. D., Gombart, A. F., Calafat, J. & other authors (2006). Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood 108, 353-361.
35. Thompson, D., Milford-Ward, A. & Whicher, J. T. (1992). The value of acute phase protein measurements in clinical practice. Ann Clin Biochem 29, 123-131.
36. Tilg, H., Dinarello, C. A. & Mier, J. (1997). IL-6 and APP: anti-inflammatory and immunosuppressive mediators. Immunol Today 18, 428-432. (Pubitemid 27381984)
37. Tolosano, E., Fagoonee, S., Hirsch, E., Berger, F. G., Baumann, H., Silengo, L. & Altruda, F. (2002). Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 100, 4201-4208. (Pubitemid 35402055)
38. Vassalli, J. D., Sappino, A. P. & Belin, D. (1991). The plasminogen activator/plasmin system. J Clin Invest 88, 1067-1072.
39. Wait, R. (2005). Reference maps of mouse serum acute-phase proteins: changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes. Proteomics 5, 4245-4253. (Pubitemid 41626092)